Empowering Excellence in Cardiac Care: At OPCI, we’re dedicated to transforming interventional cardiology education. Our mission is simple—equip healthcare professionals with advanced learning experiences to provide superior patient care. We foster a global community of cardiology experts committed to lifelong learning and excellence in medical practice
- Director, DeMatteis Cardiovascular Institute, St Francis Hospital and Heart Center
- Director, Angiographic Core Laboratory, CRF Clinical Trials Center
Dr. Ali received his medical degree with Honors and Distinction from the University of Sheffield and Doctorate in Cardiovascular Medicine Vascular Biology from the University of Oxford. Dr. Ali fulfilled a residency in internal medicine and fellowship in cardiovascular medicine at Stanford University Medical Center. He also served as Chief Fellow in cardiovascular intervention at Mount Sinai Medical Center. Prior to joining St Francis Hospital and Heart Center, Dr Ali was Associate Professor and Director of Intravascular Imaging and Physiology at Columbia University Medical Center.
- Director of Interventional Cardiology Research, St. Francis Hospital & Heart Center
- Associate Director of the Cardiac Catheterization Laboratory, St. Francis Hospital & Heart Center
- Director of the Physiology Core Laboratory, Cardiovascular Research Foundation
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high-volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is the author of more than 100 scientific articles, book chapters, and books on various aspects of intravascular imaging and coronary physiology. He is an Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital and has participated in major global studies that could impact future treatment strategies for coronary artery disease. He is the principal investigator of DEFINE PCI and DEFINE GPS, international studies assessing the improvement in blood flow after stent placement by coronary physiology, and FUSION, an OCT-based physiology assessment.
Director of Intravascular Imaging, St. Francis Hospital & Heart Center
Dr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at St. Francis Hospital – The Heart Center in Roslyn, NY. He completed a fellowship in Interventional Cardiology at Georgetown University/MedStar Washington Hospital Center. He previously completed an Intravascular Imaging and Physiology fellowship at the Cardiovascular Research Foundation (CRF) and Columbia University Medical Center (CUMC), a Cardiovascular Disease fellowship at Northwell Health and served as Chief Resident for Internal Medicine at New York Presbyterian Queens. He serves on the steering committee for the pivotal IVUS trial, IMPROVE and SCAI’s Ischemic Heart Disease Council. Dr. Shlofmitz’s research interests have centered on intravascular imaging and physiology, calcified coronary artery disease and PCI optimization, with more than 100 publications in peer-reviewed journals.
- Chairman of Cardiology, St. Francis Hospital & Heart Center
Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of OPCI. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr. Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, ILUMIEN IV, FUSION and Onyx 2.0, with more than 120 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
